Table 1 Clinical characteristics of patients in the screening cohorta.
Parameter | HCC (n = 142) | Non-HCC (n = 575) | p-value |
---|---|---|---|
Age (years) | 67 ± 9 | 59 ± 13 | <0.0001 |
Sex (female/male) | 42/100 | 326/249 | <0.0001 |
HCV viral load (log copies/mL) | 6.0 ± 1.0 | 6.2 ± 1.0 | 0.0718 |
CH/LC | 54/88 | 487/88 | <0.0001 |
AST (IU/L) | 69 ± 41 | 49 ± 34 | <0.0001 |
ALT (IU/L) | 66 ± 43 | 55 ± 49 | <0.0001 |
Platelets (×104/µL) | 12.3 ± 6.1 | 16.7 ± 6.0 | <0.0001 |
Albumin (g/dL) | 3.8 ± 0.4 | 4.2 ± 1.8 | <0.0001 |
PT% | 88 ± 18 | 99 ± 16 | <0.0001 |
AFP (ng/mL) | 630 ± 4357 | 11 ± 24 | <0.0001 |
PIVKA-II (mAU/mL) | 2098 ± 9992 | 23 ± 43 | <0.0001 |
IL28B rs8099917 (TT/TG/GG)b | 96/34/1 | 391/143/12 | 0.5660 |
ITPA rs1127354 (CC/CA/AA)b | 94/35/2 | 406/130/9 | 0.7309 |